A research team consisting of Fred Hutchinson Cancer Research Center, Columbia University Irvine Medical Center and the American Cancer Society Cancer Center Action Network (ACS CAN) have found that patients are not participating sufficiently in clinical trials not because of patient issues but rather, due to structural issues.  This upends the common notion that the cause for lack of patient participation is the fault of the patient.   See the link to the study published in the Journal of the National Cancer Institute (JCNI). These findings emphasize the enormous need to address structural and clinical barriers to trial participation, which combined make trial participation unachievable for more than three of four cancer patients.

Source: Academic Oup

Pin It on Pinterest